Literature DB >> 708991

The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition.

D M Engineer, H R Morris, P J Piper, P Sirois.   

Abstract

1 Rabbit aorta contracting substance (RCS; consisting mainly of thromboxane A2) and prostaglandin-like material were released from guinea-pig isolated perfused lungs by injection of slow reacting substance of anaphylaxis (SRS-A). 2 SRS-A was resistant to boiling and proteolytic enzymes and was therefore distinguished from rabbit aorta contracting substance releasing factor (RCS-RF). 3 The release of RCS and prostaglandin-like material by SRS-A was anatagonized by indomethacin (1 microgram/ml), betamethasone and dexamethasone (4 to 50 microgram/ml). 4 Imidazole (200 microgram/ml) inhibited the formation of thromboxane A2 but not that of prostaglandins. 5 The activity of SRS-A on guinea-pig ileum and its ability to release RCS and prostaglandins were destroyed by incubation with arylsulphatase (0.83 microgram to 1 mg/ml) and with lipoxidase (16.5 to 50 microgram/ml): SRS-A lost activity on incubation with bovine serum albumin (9 microgram/ml) due to protein binding.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708991      PMCID: PMC1668314          DOI: 10.1111/j.1476-5381.1978.tb17291.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings].

Authors:  S Bunting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Phospholipase A2 activity of guinea-pig perfused lungs: stimulation and inhibition by anti-inflammatory steroids [proceedings].

Authors:  G J Blackwell; R J Flower; F P Nijkamp; J R Vane
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

4.  Release of prostaglandins and rabbit aorta contracting substance (RCS) from guinea-pig lung by slow reacting substance of anaphylaxis (SRS-A) [proceedings].

Authors:  D M Engineer; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

5.  The relationship between prostaglandin-like substances and SRS-A released from immunologically challenged lungs [proceedings].

Authors:  J R Boot; A D Brockwell; W Dawson; W J Sweatman
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Degradation of porstaglandin F2alpha in the human pulmonary circulation.

Authors:  P Jose; U Niederhauser; P J Piper; C Robinson; A P Smith
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

7.  Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids.

Authors:  G J Blackwell; R J Flower; F P Nijkamp; J R Vane
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

8.  Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.

Authors:  P Needleman; A Raz; J A Ferrendelli; M Minkes
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.

Authors:  F P Nijkamp; S Moncada; H L White; J R Vane
Journal:  Eur J Pharmacol       Date:  1977-07-15       Impact factor: 4.432

10.  Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.

Authors:  D M Engineer; U Niederhauser; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

View more
  21 in total

1.  Comparison of rat, mouse, guinea-pig and human slow reacting substance of anaphylaxis (SRS-A).

Authors:  P Sirois; D M Engineer; P J Piper; E G Moore
Journal:  Experientia       Date:  1979-03-15

2.  Non-immunological release of slow-reacting substance from guinea-pig lungs.

Authors:  P J Piper; J P Seale
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

3.  Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.

Authors:  T Torii; Y Toki; N Hieda; Y Ito; K Okumura; H Hashimoto; T Ito; K Ogawa; T Satake
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

Review 4.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

5.  Pharmacologic characterization of immune complex induced bronchoconstriction in guinea pigs.

Authors:  Z E Mielens; E W Ferguson; R A Ferrari
Journal:  Agents Actions       Date:  1981-12

6.  Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro.

Authors:  P J Piper; M N Samhoun
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

7.  Pharmacological modulation of endothelin-induced contraction of guinea-pig isolated airways and thromboxane release.

Authors:  J G Filep; B Battistini; P Sirois
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

8.  In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.

Authors:  A F Welton; W C Hope; H J Crowley; R A Salvador
Journal:  Agents Actions       Date:  1981-07

9.  Beta 2-adrenoceptor blockade is the basis of guinea-pig bronchial hyper-responsiveness to leukotriene C4 and other agonists.

Authors:  S Bongrani; G C Folco; R Razzetti; P Schiantarelli
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  Atropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig.

Authors:  F Berti; G C Folco; A Giachetti; S Malandrino; C Omini; T Viganò
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.